ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.691,32
0,05%
S&P 500
5.267,84
-0,74%
Dow Jones
39.065,26
-1,53%
Euro vs US Dollar
1,08086
-0,03%
Bitcoin
67.870,82
-0,08%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) News

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPRXOptimizeRx Corporation
14/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
07/05/202403h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
07/05/202403h34Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
07/05/202403h32Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:OPRXOptimizeRx Corporation
11/03/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
06/03/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
22/02/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
22/02/202400h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
22/02/202400h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
22/02/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
14/02/202423h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
14/02/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
26/01/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
11/01/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
09/01/202422h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPRXOptimizeRx Corporation
05/01/202423h19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPRXOptimizeRx Corporation
29/12/202323h30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
28/11/202322h10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OPRXOptimizeRx Corporation
13/11/202320h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/11/202313h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
03/11/202315h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
30/10/202321h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
25/10/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
16/10/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPRXOptimizeRx Corporation
12/10/202320h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/10/202320h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/10/202320h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/10/202320h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
06/10/202320h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Kürzlich von Ihnen besucht

AQSE
GBJP.GB
WisdomTree Commodity Sec...
MRTX
BTPETH
BitcoinPublic
COIN
SPDCEUR
EU
3470T
3470T
LBNK
NESTUSDT
NEST
TSXV
RW
RenoWorks Software
AMEX
TDSC
Cabana Target Drawdown 1...
BIT
P1VSG6
NLBNPIT1VSG6 20991231 11...
EU
D694S
D694S
USOTC
SXRIU
Sioux River Ethanol (GM)
NYSE
DNA
Ginkgo Bioworks
DBI
0J4U
VVSTOXX December 2023
COIN
8BITGBP
BIT
P1VTR1
NLBNPIT1VTR1 20241220 180
KOSPI
012330
Hyundai Mobis
COIN
VCCEUR
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten